Please login to the form below

Not currently logged in
Email:
Password:

NHS boss resigns ahead of 'damning' report

The chief executive of Birmingham Children's Hospital has resigned with immediate effect ahead of the publication of a report by the Healthcare Commission

The chief executive of Birmingham Children's Hospital has resigned with immediate effect ahead of the publication of a report by the Healthcare Commission, which investigated the hospital after concerns were raised by its own doctors.

This week's Sunday Observer newspaper reported that the leading children's hospital is to be censured by the NHS watchdog. The Healthcare Commission will issue a highly critical report highlighting numerous failings in both quality of care and management processes.

Birmingham Children's Hospital NHS Foundation Trust chairwoman Joanna Davis confirmed that the chief Paul O'Connor has resigned and "has not been removed from his position".

The investigation, which was launched in November after the Observer obtained an internal NHS report which looked at the clinical standards at the children's hospital questioning consultants across different departments. The Observer stated the report, commissioned by the NHS Primary Care Trusts in Birmingham, found that support for surgeons undertaking kidney transplants at the hospital was poor and transplant services for children with serious liver failure were like "a third-class service [that is] putting patients at risk."

A Birmingham Children's Hospital spokeswoman said: "We can answer questions when the Healthcare Commission's report is out, but we cannot make any comments until that happens."

9th March 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics